Author: admin-sx

SpeeDx signed a collaboration agreement with GSK to provide tests and custom test development to support antibiotic clinical trials and new product development. "We welcome this extension of the utility...

SpeeDx Pty, Ltd. announced an agreement with Cepheid to manufacture their market-leading ResistancePlus® tests for use on the GeneXpert System. The first test in Cepheid’s FleXible Cartridge programme, planned for...

SpeeDx have successfully settled into new U.S. Headquarters at the Texas Health CoLab in Austin Texas. Chosen for its synergy in supporting progressive and innovative health solutions, the technology hub...

New distribution partners, Al Zahrawi Medical Supplies LLC, will distribute SpeeDx ResistancePlus® and PlexPCR® tests across UAE, Saudi Arabia, Oman, Bahrain, and Qatar. “Al Zahrawi Medical are the leading medical and...

ResistancePlus® GC received clearance from the Australian Therapeutic Goods Administration (TGA) today. Launched in December with CE-IVD mark for sale in Europe, Australian laboratories can now access this world-first diagnostic...